Citius Pharmaceuticals (CTXR) Earnings Date & Reports
Citius Pharmaceuticals Inc is a biopharmaceutical company with a focus on anti-infectives in adjunct cancer care, prescription products, and stem cell therapy... Show more
CTXR is expected to report earnings to fall 96.06% to -5 cents per share on November 27
Q3'24
Est.
$-0.05
Q1'25
Missed
by $1.31
Q2'24
Missed
by $0.01
Q1'24
Est.
$-0.05
Q4'23
Missed
by $0.19
The last earnings report on May 14 showed earnings per share of -126 cents, missing the estimate of 3 cents. With 106.41K shares outstanding, the current market capitalization sits at 8.54M.